Michael Ouk

493 total citations
15 papers, 348 citations indexed

About

Michael Ouk is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Michael Ouk has authored 15 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Michael Ouk's work include Alzheimer's disease research and treatments (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Diabetes Treatment and Management (3 papers). Michael Ouk is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Diabetes Treatment and Management (3 papers). Michael Ouk collaborates with scholars based in Canada, Germany and Brazil. Michael Ouk's co-authors include Walter Swardfager, Che‐Yuan Wu, Krista L. Lanctôt, Nathan Herrmann, Sandra E. Black, Jodi D. Edwards, Jennifer S. Rabin, Di Yu, Baiju R. Shah and Richard H. Swartz and has published in prestigious journals such as Stroke, Neuroscience & Biobehavioral Reviews and Neurobiology of Aging.

In The Last Decade

Michael Ouk

14 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ouk Canada 11 133 105 87 58 54 15 348
Valentina Fardella Italy 8 120 0.9× 177 1.7× 105 1.2× 137 2.4× 66 1.2× 10 487
Hairong Liao China 5 127 1.0× 70 0.7× 86 1.0× 26 0.4× 77 1.4× 9 337
Fabio Pallante Italy 10 125 0.9× 206 2.0× 114 1.3× 171 2.9× 67 1.2× 12 555
Zhenjie Teng China 12 65 0.5× 115 1.1× 65 0.7× 62 1.1× 32 0.6× 25 375
Melda Bozluolçay Türkiye 11 90 0.7× 66 0.6× 72 0.8× 63 1.1× 65 1.2× 26 404
M.R. Munari Italy 7 241 1.8× 220 2.1× 109 1.3× 40 0.7× 67 1.2× 9 521
Heba A. Ahmed United States 13 58 0.4× 126 1.2× 117 1.3× 105 1.8× 19 0.4× 28 346
Alecia Seliga United States 6 107 0.8× 155 1.5× 93 1.1× 21 0.4× 11 0.2× 8 436
Di Yu Canada 10 108 0.8× 117 1.1× 61 0.7× 10 0.2× 61 1.1× 13 406

Countries citing papers authored by Michael Ouk

Since Specialization
Citations

This map shows the geographic impact of Michael Ouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ouk more than expected).

Fields of papers citing papers by Michael Ouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ouk. The network helps show where Michael Ouk may publish in the future.

Co-authorship network of co-authors of Michael Ouk

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ouk. A scholar is included among the top collaborators of Michael Ouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ouk. Michael Ouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wu, Che‐Yuan, Michael Ouk, Bradley J. MacIntosh, et al.. (2022). Glucose-lowering drugs, cognition, and dementia: The clinical evidence. Neuroscience & Biobehavioral Reviews. 137. 104654–104654. 10 indexed citations
2.
Wu, Che‐Yuan, Di Yu, Esther Kim, et al.. (2022). Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis. Parkinsonism & Related Disorders. 101. 119–128. 26 indexed citations
3.
Wu, Che‐Yuan, Michael Ouk, Jennifer S. Rabin, et al.. (2022). Gastric acid suppressants and cognitive decline in people with or without cognitive impairment. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12243–e12243. 10 indexed citations
4.
Wu, Che‐Yuan, Michael Ouk, Ming Hui Chen, et al.. (2022). Endosomal-Lysosomal and Autophagy Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer s Disease. 88(4). 1279–1292. 16 indexed citations
5.
Ouk, Michael, Che‐Yuan Wu, Jennifer S. Rabin, et al.. (2021). Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia. Alzheimer s Research & Therapy. 13(1). 147–147. 16 indexed citations
7.
MacIntosh, Bradley J., Jiming Fang, Limei Zhou, et al.. (2021). Diabetes Mellitus Is Associated With Poor In‐Hospital and Long‐Term Outcomes in Young and Midlife Stroke Survivors. Journal of the American Heart Association. 10(14). e019991–e019991. 11 indexed citations
8.
Ouk, Michael, Che‐Yuan Wu, Jennifer S. Rabin, et al.. (2021). Leukotriene receptor antagonist use is associated with slower cognitive decline in Alzheimer’s disease. Alzheimer s & Dementia. 17(S6). 1 indexed citations
9.
Wu, Che‐Yuan, Michael Ouk, Di Yu, et al.. (2020). Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid. Ageing Research Reviews. 62. 101130–101130. 40 indexed citations
10.
Ouk, Michael, Che‐Yuan Wu, Jennifer S. Rabin, et al.. (2020). Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. Neurobiology of Aging. 100. 22–31. 24 indexed citations
11.
Herrmann, Nathan, Hugo Cogo‐Moreira, Michael Ouk, et al.. (2020). A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease. Journal of Neuroinflammation. 17(1). 84–84. 50 indexed citations
12.
Ouk, Michael, et al.. (2020). Psychiatric morbidity and cervical cancer screening: a retrospective population-based case–cohort study. CMAJ Open. 8(1). E134–E141. 12 indexed citations
13.
Wu, Che‐Yuan, Michael Ouk, Jodi D. Edwards, et al.. (2020). Relationships between oral hypoglycemic drugs and memory decline in people with type 2 diabetes: A stratified longitudinal observational study. Alzheimer s & Dementia. 16(S6). 1 indexed citations
14.
Wu, Che‐Yuan, Michael Ouk, Jodi D. Edwards, et al.. (2020). Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status. Alzheimer s & Dementia. 16(12). 1663–1673. 66 indexed citations
15.
Ouk, Michael, Che‐Yuan Wu, Jiming Fang, et al.. (2020). Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke. Stroke. 51(12). 3531–3540. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026